ANALYSIS: Budget to invest more in Elevate Fund as part of the Coalition’s growth agenda.
ANALYSIS: A reminder that trustees can be personally liable for breaching their duty to invest prudently, diversely.
ANALYSIS: Whether a look to the past can help form expectations about what might occur in the future.
ANALYSIS: Shareholders have legitimate concerns about the independence of listed publican’s sale.
ANALYSIS: If giant offshore windfarms require price support mechanisms to be viable, the incoming Government will not be keen.
ANALYSIS: Introducing 10 bills to Parliament – which still have to be drafted – will take time.
ANALYSIS: NBR Listers’ pharma company cleared a major FDA hurdle last week but winning the US is far from assured.
ANALYSIS: A new government does not meaningfully change the prevailing fundamentals for most companies.
ANALYSIS: A recommendation that a new independent regulator be established shouldn't fall to the bottom of the new government's legislative priorities.
ANALYSIS: As a dispute over potential liability for bursting pipes in Australia escalates, there are still big holes in each side’s arguments.